Anovo Blog

Cycle Pharmaceuticals and Anovo Deliver Relief to Those with Homozygous Cystinuria

Cycle Pharmaceuticals was founded in 2012 with one mission in mind: delivering best-in-class drug treatments and services to the underserved…

read more

Cycle Pharmaceuticals and Anovo Deliver Relief to Those with Homozygous Cystinuria
Advancing Rare Disease Care: Insights from the World Orphan Drug Congress and AAN Annual Meeting

Advancing Rare Disease Care: Insights from the World Orphan Drug Congress and AAN Annual Meeting

The World Orphan Drug Congress (WODC) and the American Academy of Neurology (AAN) Annual Meeting are where healthcare leaders, advocates,…

June 11, 2024

Pyros and Anovo Partner to Elevate Care for Infantile Spasms

Pyros and Anovo Partner to Elevate Care for Infantile Spasms

Pyros Pharmaceuticals works to elevate the standard of care for children with rare disease by pioneering treatment options like VIGPODER™…

April 1, 2024

Jill’s Story: Advocating for Patients with Acromegaly

Jill’s Story: Advocating for Patients with Acromegaly

Jill Sisco isn’t just an advocate – she’s also a patient herself. She’s been living with Acromegaly, a rare disease…

March 6, 2024

Celebrating Five Consecutive Years as a Top Workplace at Anovo

Celebrating Five Consecutive Years as a Top Workplace at Anovo

We are thrilled to announce that Anovo has been recognized as a top workplace by The Commercial Appeal for the…

February 6, 2024

FDA Releases Final Guidance on Rare Disease Drug Development

FDA Releases Final Guidance on Rare Disease Drug Development

The FDA recently released its final guidance on rare disease drug development, which will have several significant implications for orphan…

January 4, 2024

Egetis Therapeutics & Anovo Unite for MCT8 Patients

Egetis Therapeutics & Anovo Unite for MCT8 Patients

Egetis Therapeutics is an innovative pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases…

January 2, 2024

Braynelle’s Story: Living with Dravet Syndrome 

Braynelle’s Story: Living with Dravet Syndrome 

Braynelle and Brandon have been managing their son Kai’s diagnosis of Dravet Syndrome since he was four months old. After…

December 3, 2023

Scott’s Story: Living with Lambert-Eaton Myasthenic Syndrome 

Scott’s Story: Living with Lambert-Eaton Myasthenic Syndrome 

Experience Scott’s extraordinary journey living with Lambert-Eaton myasthenic syndrome (LEMS), where for over a decade, he’s been his own advocate,…

November 15, 2023

Kevin’s Story: Living with Lambert-Eaton Myasthenic Syndrome 

Kevin’s Story: Living with Lambert-Eaton Myasthenic Syndrome 

Meet Kevin, an Anovo patient living with Lambert-Eaton myasthenic syndrome. Despite the challenges he’s faced in not always being able…

November 1, 2023

Acadia and Anovo Partner to Transform Rett Syndrome Care

Acadia and Anovo Partner to Transform Rett Syndrome Care

Acadia Pharmaceuticals, Inc. is a pioneering biopharmaceutical company dedicated to transforming the treatment landscape for central nervous system (CNS) disorders….

October 3, 2023

Anovo Recognized for Creation of “End-to-End” Service Model that Benefits Both Patients and Manufacturers 

Anovo Recognized for Creation of “End-to-End” Service Model that Benefits Both Patients and Manufacturers 

Anovo is excited to announce that we have been featured in an article for USA Today, which details our unique…

September 5, 2023

It starts with a conversation. Contact us today.

close